Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2

Jing Fang1, Cheng-Cao Sun2, Cheng Gong3

  • 1Department of Oncology, Wuhan Pu-Ai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430034, PR China.

Insights

Long noncoding RNAs (lncRNAs) like XIST promote non-small cell lung cancer (NSCLC) growth. Silencing XIST inhibits NSCLC progression by regulating KLF2 expression, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) are key regulators in cancer.
  • XIST, an oncogenic lncRNA in other cancers, has an unknown role in non-small cell lung cancer (NSCLC).

Purpose of the Study:

  • To investigate the role and mechanism of XIST in NSCLC tumorigenesis.

Main Methods:

  • Quantitative real-time PCR to assess XIST expression.
  • In vitro assays (proliferation, migration, invasion) and in vivo tumorigenicity assays.
  • RNA immunoprecipitation (RIP) and RNA pull-down assays to identify molecular interactions.
  • Rescue experiments to validate mechanistic findings.

Main Results:

  • XIST was over-expressed in NSCLC tissues and correlated with poor prognosis.
  • XIST knockdown suppressed NSCLC cell proliferation, migration, invasion, and in vivo tumor growth.
  • XIST directly interacted with EZH2 to suppress KLF2 transcription.
  • KLF2 silencing partially mediated XIST's oncogenic functions.

Conclusions:

  • XIST acts as an oncogenic lncRNA in NSCLC by suppressing KLF2 via EZH2.
  • XIST is a potential therapeutic target for NSCLC treatment.

Related Concept Videos

Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.9K